Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nat Neurosci ; 26(7): 1185-1195, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37277487

RESUMO

Neurons, astrocytes and oligodendrocytes locally regulate protein translation within distal processes. Here, we tested whether there is regulated local translation within peripheral microglial processes (PeMPs) from mouse brain. We show that PeMPs contain ribosomes that engage in de novo protein synthesis, and these are associated with transcripts involved in pathogen defense, motility and phagocytosis. Using a live slice preparation, we further show that acute translation blockade impairs the formation of PeMP phagocytic cups, the localization of lysosomal proteins within them, and phagocytosis of apoptotic cells and pathogen-like particles. Finally, PeMPs severed from their somata exhibit and require de novo local protein synthesis to effectively surround pathogen-like particles. Collectively, these data argue for regulated local translation in PeMPs and indicate a need for new translation to support dynamic microglial functions.


Assuntos
Microglia , Fagocitose , Camundongos , Animais , Microglia/metabolismo , Fagocitose/fisiologia , Neurônios/metabolismo , Astrócitos/metabolismo
2.
Mo Med ; 120(1): 70-78, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36860601

RESUMO

As our population ages, there is interest in delaying or intervening in cognitive decline. While newer agents are under development, agents in mainstream use do not impact the course of diseases that cause cognitive decline. This increases interest in alternative strategies. Even as we welcome possible new disease-modifying agents, they are likely to remain costly. Herein, we review the evidence behind other complementary and alternative strategies for cognitive enhancement and prevention of cognitive decline.


Assuntos
Doença de Alzheimer , Disfunção Cognitiva , Terapias Complementares , Humanos , Doença de Alzheimer/terapia , Transtornos Neurocognitivos , Disfunção Cognitiva/terapia
3.
Cell Rep ; 33(12): 108531, 2020 12 22.
Artigo em Inglês | MEDLINE | ID: mdl-33357440

RESUMO

CELF6 is a CELF-RNA-binding protein, and thus part of a protein family with roles in human disease; however, its mRNA targets in the brain are largely unknown. Using cross-linking immunoprecipitation and sequencing (CLIP-seq), we define its CNS targets, which are enriched for 3' UTRs in synaptic protein-coding genes. Using a massively parallel reporter assay framework, we test the consequence of CELF6 expression on target sequences, with and without mutating putative binding motifs. Where CELF6 exerts an effect on sequences, it is largely to decrease RNA abundance, which is reversed by mutating UGU-rich motifs. This is also the case for CELF3-5, with a protein-dependent effect on magnitude. Finally, we demonstrate that targets are derepressed in CELF6-mutant mice, and at least two key CNS proteins, FOS and FGF13, show altered protein expression levels and localization. Our works find, in addition to previously identified roles in splicing, that CELF6 is associated with repression of its CNS targets via the 3' UTR in vivo.


Assuntos
Proteínas CELF/metabolismo , RNA Mensageiro/metabolismo , Sinapses/metabolismo , Regiões 3' não Traduzidas , Animais , Encéfalo/metabolismo , Proteínas CELF/genética , Linhagem Celular Tumoral , Feminino , Humanos , Masculino , Camundongos , RNA Mensageiro/genética , Ribossomos/genética , Ribossomos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA